Abstract
Until recently, plastic endoprostheses were routinely used for initial clearance of jaundice in pancreatic cancer patients (pts) until surgical candidacy or palliative care was established. Recent experience suggests all stages of pancreatic cancer pts have the potential to benefit from SEMS in view of their superior performance and low risk. Given that use in palliative pts is cost effective, we report growing experience with SEMS placement in surgical or borderline surgical pts.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
